
Dapatimi M 10mg/500mg Tablet SR
Marketer
Vishaura Healthcare Private Limited
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapatimi M 10mg/500mg Tablet SR
Combiflex DM 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This treatment effectively lowers elevated blood glucose, mitigating the risk of serious diabetic complications, including heart disease. Combiflex DM 10mg/500mg ER Tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician and should not be altered without consultation, as abrupt cessation may elevate blood sugar, potentially leading to severe consequences such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, physical activity, and weight management as directed by your doctor. Common side effects may include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is recommended to prevent dehydration. Genital fungal infections are a potential side effect, manageable with diligent hygiene practices. Prior to commencing treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption to minimize potential side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Dapatimi M 10mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Dapatimi M 10mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapatimi M 10mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.
Common Side effects of Dapatimi M 10mg/500mg Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapatimi M 10mg/500mg Tablet SR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dapatimi M 10mg/500mg Tablet SR with a meal.
How Dapatimi M 10mg/500mg Tablet SR works:
Dapatimi M 10mg/500mg Extended-Release Tablets contain dapagliflozin and metformin, two medications used to manage diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose output, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action contributes to improved glycemic management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Dapatimi M 10mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapatimi M 10mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Dapatimi M 10mg/500mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Dapatimi M 10mg/500mg SR tablets to individuals with impaired kidney function. Dosage modification of Dapatimi M 10mg/500mg SR tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dapatimi M 10mg/500mg sustained-release tablets. Dosage modification of Dapatimi M 10mg/500mg sustained-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Dapatimi M 10mg/500mg Tablet SR :
Should you forget a dose of Dapatimi M 10mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapatimi M 10mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
